Use patterns of systemic immunomodulators in the United States before and after dupilumab approval in adults with atopic dermatitis
Sign Up to like & getrecommendations! Published in 2022 at "Pharmacoepidemiology and Drug Safety"
DOI: 10.1002/pds.5586
Abstract: The patterns of dupilumab use, the first systemic drug approved for the treatment of atopic dermatitis (AD), is not well understood in the context of offâlabel systemic medications. read more here.
Keywords: systemic immunomodulators; use patterns; patterns systemic; atopic dermatitis ... See more keywords